BBOT
BridgeBio Oncology Therapeutics, Inc.Company with tickers: BBOT
CIK
1869105
CUSIP
107924102
Shares Outstanding
80,107,104
13F Activity (30d)
66 filings
66 filers
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | — | ||||
| Cost of Revenue | — | ||||
| Gross Profit | — | ||||
| Operating Expenses | $46,179,000 | USD | 2026-03-31 | 10-Q | 2026-05-12 |
| Research & Development | $39,802,000 | USD | 2026-03-31 | 10-Q | 2026-05-12 |
| Operating Income | $-46,179,000 | USD | 2026-03-31 | 10-Q | 2026-05-12 |
| Net Income | $-42,106,000 | USD | 2026-03-31 | 10-Q | 2026-05-12 |
| EPS (Basic) | $-526.11 | USD/shares | 2026-03-31 | 10-Q | 2026-05-12 |
| EPS (Diluted) | $-526.11 | USD/shares | 2026-03-31 | 10-Q | 2026-05-12 |